Skip to content
Search

Latest Stories

CPE, pharmacy owners and LPCs meet to discuss sector’s topical and strategic issues

Community Pharmacy England, pharmacy owners and LPCs met in Leeds to discuss urgent matters such as pharmacy pressures and the ongoing Primary Care Access Plan negotiations, with valuable input from sector polls and LPC leaders.

The packed two-day meeting held on 12th and 13th July, agenda included time to consider both topical and more strategic issues, with matters arising from the ongoing negotiations of the additional £645 million investment in community pharmacy high on the agenda.


The Committee discussed progress and explored how to get as much money flowing into pharmacies as possible from this opportunity, without adding further pressures.

In a first for the Committee, CPE asked the sector a series of questions ahead of the meeting and Committee Members had a full discussion on the results. It has already begun using some of the results in its influencing work and the Negotiating Team is currently considering how they may be used to support the ongoing and future negotiations.

Janet Morrison, Chief Executive of Community Pharmacy England, said: “July’s meeting came at an important moment, allowing us to discuss key topics that will feed into the ongoing negotiations. We spent a substantial amount of time considering the overarching critical issues and what the Committee identified to be the priorities and red lines. At this critical stage, we are grateful to everyone who completed our polls as your feedback has been incredibly valuable.

“Enabling pharmacy owners to feed directly into Community Pharmacy England Committee meetings is a key strand of our new ways of working with the sector. Never before have pharmacy owners been able to directly inform our Committee and have their opinions discussed at length as an agenda item in its own right.

“The results of the polls weren’t easy reading and laid bare the struggles that pharmacies have to manage on a daily basis.  In particular the Committee noted the severe pressures being faced by pharmacy owners in terms of the ongoing instability of generic medicines supply, dispensing at a loss and margin delivery within the constraints of Year 5 of the contract.  It’s important that Committee Members hear this kind of feedback to help ensure they can accurately represent and make the best decisions for the whole sector. It also helps us to raise awareness of issues that matter to you with the public and policymakers.”

“As part of our commitment to unity and working collaboratively across the sector, the Committee were joined by LPC leaders from the Yorkshire and Humber region for part of the meeting. The LPC attendees had the chance to network with Committee Members and speak about their experiences of local commissioning, working with Integrated Commissioning Boards (ICBs) and other local issues,” said CPE.

Committee Members also discussed progress on the Vision for Community Pharmacy being developed by Nuffield Trust and The King’s Fund, as well as a new draft governance framework from independent expert Victoria Finney, who is leading a comprehensive governance review of the Committee.

This is the first update in its new approach for post-Committee Meeting communications since CPE’s recent rebrand. It will continue to keep the sector updated about Committee Meetings in a variety of ways going forward to keep pharmacy owners and their teams more informed about work.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less